Skip to main content
- Funds
- Insights
- Capabilities
- About Us
- My Account
15 June 2021 – I am very pleased to provide an update on our firm’s leadership. Effective 1 July 2021, Terry Burgess will join Jean Hynes and Steve Klar as one of three Managing Partners of Wellington Management Group, LLP. Terry was elected by the Partners to succeed me as Managing Partner following my retirement on 30 June 2021. Separately, as previously announced, Jean Hynes will succeed me as CEO.
Terry is the head of Investment Boutiques, which includes nearly 50 investment teams working across asset classes and around the world. He will continue in this role in addition to assuming the responsibilities of Managing Partner. Over the course of his 15 years at the firm, Terry has held a variety of management roles across product and investment groups, including serving as head of Investment Research. He has served on a variety of firmwide committees, and he became a Partner in 2014.
Prior to joining the firm in 2005, Terry held various positions at MFS Investment Management (1993 – 2005), including equity analyst covering basic resources, cable, media, and telecom. He earned his MBA from Boston College (1999) and his BA in economics and political science from Bates College (1993).
Sincerely,
Brendan J. Swords
CEO
2026 Private Credit Roundtable
In this three-part video series, our private credit experts explore the evolving role of banks, where we are in the credit cycle, and potential AI/data center opportunities in private credit.
Private Market Perspectives 2025: Full Picture
At our Annual Meeting, we explored private markets trends, from private credit growth to opportunities across the credit continuum, powered by our integrated public and private insight.
Monthly Market Review — January 2026
A monthly update on equity, fixed income, currency, and commodity markets.
Secondary investment: Flexibility in private equity
Our private equity experts highlight how secondary transactions offer liquidity solutions for LPs, capital support for GPs, and a growing opportunity set.
European equities: time to reassess?
Many investors remain cautious on European equities, but Multi-Asset Portfolio Manager Supriya Menon and Lead Researcher Patrick Wattiau argue it is time to consider what could go right for European equities.
Don’t stop believin’ in emerging market equities
Multi-Asset Strategist Nanette Abuhoff Jacobson explains why emerging market equities have become her highest-conviction view across asset classes.
3 reasons to believe in Chinese equities
Macro Strategist Johnny Yu explores China's equity market resurgence, highlighting innovation, US-China relations, and policy shifts towards quality growth.
JPY intervention: what makes it so important this time?
Fixed Income Portfolio Managers Sam Hogg and Ed Meyi and Investment Director Takashi Nakao explore what’s different about the unconfirmed but likely JPY intervention and why it matters for global investors.
Another banner year for emerging markets local debt in 2026?
Our experts highlight EM local debt's strong 2025 performance and explain their bullish outlook for 2026.
Disquiet in quality: What happened and what now?
Quality has been lagging since 2021, with underperformance accelerating sharply in 2025. Where does this leave investors now?
China’s biotech surge (and its impact on biotech venture capital)
China’s biotech sector’s long-term potential is underpinned by lower costs, faster development timelines, and increasingly translatable clinical data. In our new paper, we explore the implications for US and European biotechs.
URL References
Related Insights